Adjuvant Chemotherapy for Non-Small Cell Lung Cancer

被引：0
作者：
D'Amico, Thomas A. [1 ]
机构：
[1] Duke Univ, Med Ctr, Div Thorac Surg, Durham, NC USA
来源：
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY | 2005年 / 17卷 / 03期
关键词：
lung cancer; adjuvant therapy; targeted therapy; outcomes;
D O I：
10.1053/j.semtcvs.2005.06.010
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The survival after complete resection for non-small cell lung cancer (NSCLC) is unsatisfactory. Until recently, the use of adjuvant therapy after resection for early stage disease has not been proven to improve survival. However, the efficacy of adjuvant therapy has been demonstrated in phase III prospective randomized trials. The appropriate use of adjuvant therapy, including biologic therapy, is currently under investigation. © 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码：195 / 198
页数：4
相关论文
共 21 条
  • [1] ALBERTI W, 1995, BRIT MED J, V311, P899
  • [2] [Anonymous], 2004, J NATL CANC COMPR NE, V2, P94
  • [3] SITES OF RECURRENCE IN RESECTED STAGE-I NON-SMALL-CELL LUNG-CANCER - A GUIDE FOR FUTURE STUDIES
    FELD, R
    RUBINSTEIN, LV
    WEISENBERGER, TH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (12) : 1352 - 1358
  • [4] Gatzemeier U, 2004, J CLIN ONCOL, V22, p619S
  • [5] Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase III trial-INTACT1
    Giaccone, G
    Herbst, RS
    Manegold, C
    Scagliotti, G
    Rosell, R
    Miller, V
    Natale, RB
    Schiller, JH
    von Pawel, J
    Pluzanska, A
    Gatzemeier, M
    Grous, J
    Ochs, JS
    Averbuch, SD
    Wolf, MK
    Rennie, P
    Fandi, A
    Johnson, DH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) : 777 - 784
  • [6] Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: A phase III trial - INTACT 2
    Herbst, RS
    Giaccone, G
    Schiller, JH
    Natale, RB
    Miller, V
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) : 785 - 794
  • [7] Holmes EC, 1991, LUNG CANCER, V7, P11
  • [8] Cancer statistics, 2005
    Jemal, A
    Murray, T
    Ward, E
    Samuels, A
    Tiwari, RC
    Ghafoor, A
    Feuer, EJ
    Thun, MJ
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (01) : 10 - 30
  • [9] A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small-cell lung cancer.
    Keller, SM
    Adak, S
    Wagner, H
    Herskovic, A
    Komaki, R
    Brooks, BJ
    Perry, MC
    Livingston, RB
    Johnson, DH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (17) : 1217 - 1222
  • [10] Emerging role of epidermal growth factor receptor inhibition in therapy for advanced malignancy: Focus on NSCLC
    Langer, CJ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (03): : 991 - 1002
123